Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/26/11 → 8/6/13 |
Funding
- Mapi USA, Inc. (MRZ 60201-4066-5 // MRZ 60201-4066-5)
- Merz Pharmaceuticals, LLC (MRZ 60201-4066-5 // MRZ 60201-4066-5)
MRZ 60201-4066-5: Prospective, Observational Trial Evaluating Xeomin(Incobotulinumtoxin A) for Cervical Dystonia or Blepharospasm in the United States
- Zadikoff, Cindy (PD/PI)
- Simuni, Tatyana (Co-Investigator)
Project: Research project